𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Systemic Combined Chemotherapy with Low Dose of 5-Fluorouracil, Cisplatin, and Interferon-α for Advanced Hepatocellular Carcinoma: A Pilot Study

✍ Scribed by Yasuji Komorizono; Kazunori Kohara; Makoto Oketani; Masahiko Maeda; Toshihiko Shibathou; Shuhou Shigenobu; Yasusi Hiramine; Naruhiro Yamasaki; Takushi Arima; Ishibashi Kazuaki; Terukatsu Arima

Book ID
110430994
Publisher
Springer US
Year
2003
Tongue
English
Weight
30 KB
Volume
48
Category
Article
ISSN
0163-2116

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pilot study of combination chemotherapy
Pilot study of combination chemotherapy of S-1, a novel oral DPD inhibitor, and interferon-α for advanced hepatocellular carcinoma with extrahepatic metastasis
✍ Masato Nakamura; Hiroaki Nagano; Shigeru Marubashi; Atsushi Miyamoto; Yutaka Tak 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

## Abstract ## BACKGROUND. To the authors' knowledge, there is no effective therapy for extrahepatic metastasis of hepatocellular carcinoma (HCC). In a pilot study, the results of combination therapy of S‐1, a novel oral dehydropyrimidine dehydrogenase (DPD) inhibitor, and interferon‐alpha (IFN‐α)

Phase II trial of 5-fluorouracil, leucov
Phase II trial of 5-fluorouracil, leucovorin, interferon-α-2a, and cisplatin as neoadjuvant chemotherapy for locally advanced esophageal carcinoma
✍ Barbara K. Temeck; James E. Liebmann; Christopher Theodossiou; Seth M. Steinberg 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 635 KB

## BACKGROUND. Most patients with esophageal carcinoma present with locally advanced disease and a poor prognosis. Surgery or radiation provides palliation for locally advanced esophageal carcinoma. The role of neoadjuvant therapy remains to be defined. We administered neoadjuvant chemotherapy cons